Bempedoic Acid for Prevention of Cardiovascular Events in People With Obesity: A CLEAR Outcomes Subset Analysis
Background Obesity and hypercholesterolemia independently increase cardiovascular disease risk. This analysis evaluated the efficacy and safety of bempedoic acid in people with obesity participating in the CLEAR (Cholesterol Lowering via Bempedoic Acid [ECT1002], an ACL‐Inhibiting Regimen) Outcomes...
Saved in:
| Main Authors: | Harold E. Bays, LeAnne Bloedon, Danielle Brennan, Lei Lei, A. Michael Lincoff, Stephen J. Nicholls, Jorge Plutzky, Heather A. Powell, Steven E. Nissen |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-02-01
|
| Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Subjects: | |
| Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.124.037898 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reshaping Dyslipidaemia Treatment with Bempedoic Acid—A Narrative Review
by: Dominik Strikic, et al.
Published: (2025-06-01) -
Triple Non-Statin Therapy with Ezetimibe, Inclisiran, and Bempedoic Acid in Patients with Genetically Confirmed Statin-Induced Rhabdomyolysis: A Dual Case Report
by: Jozef Dodulík, et al.
Published: (2025-05-01) -
The Pathogenetic Basis of the Action of Bempedoic Acid
by: A. S. Petrosyan, et al.
Published: (2023-01-01) -
Bempedoic Acid in Patients with Dyslipidemia: A Systematic Review and Meta-Analysis
by: Shambo S. Samajdar, et al.
Published: (2025-05-01) -
Addition of Bempedoic Acid to Statin–Ezetimibe versus Statin Titration in Patients with High Cardiovascular Risk: A Single-Centre Prospective Study
by: Giuseppe Marazzi, et al.
Published: (2024-09-01)